Stone disease - Results from #200

An Indian surgeon's perspective on management of asymptomatic gallstones. March 11, 2024

Deficient butyrate metabolism in the intestinal microbiome is a potential risk factor for recurrent kidney stone disease. March 11, 2024

Use of artificial stones in training and laboratory studies, have we found the right material? Outcomes of a systematic review from the European School of Urology. March 4, 2024

Comparing Same Sitting Bilateral vs Unilateral RIRS in the Elderly. March 4, 2024

Kidney collecting system anatomy applied to endourology - a narrative review. March 4, 2024

Evaluation of ChatGPT for Patient Counseling in Kidney Stone Clinic: A Prospective Study. March 4, 2024

Epidemiological and biological associations between cardiovascular disease and kidney stone formation: A systematic review and meta-analysis. March 4, 2024

Real-World Effectiveness of Preventive Pharmacological Therapy in Patients With Urolithiasis: A Retrospective Cohort Study. March 4, 2024

Supine mini percutaneous nephrolithotomy in horseshoe kidney. February 26, 2024

Concurrent two surgeon approach for bilateral synchronous percutaneous nephrolithotomy: Initial experience at a University Teaching Hospital. February 26, 2024

Ferroptosis and its emerging role in kidney stone formation. February 26, 2024

Urological Guidelines for Kidney Stones: Overview and Comprehensive Update. February 26, 2024

Retrograde intrarenal surgery for asymptomatic incidental renal stones: a retrospective, real-world data analysis. February 19, 2024

Preventive Pharmacological Therapy and Risk of Recurrent Urinary Stone Disease. February 19, 2024

The impact of kidney stone disease on quality of life in high-risk stone formers. February 12, 2024

Safety and efficacy of 'Dusting and Pop-dusting' with high power laser for treatment of large stones with ureteroscopy and lasertripsy (URSL): Prospective outcomes from a university teaching hospital. February 12, 2024

Allopurinol hypersensitivity syndrome: Raising awareness of an uncommon but potentially serious adverse event among kidney stone patients. February 12, 2024

A two-sample mendelian randomization analysis excludes causal relationships between non-alcoholic fatty liver disease and kidney stones. February 5, 2024

Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients With Type 2 Diabetes. February 5, 2024

Is traditional stone clinic the optimal use of NHS resources? February 5, 2024

Page 11 of 137